Literature DB >> 8337709

Abdominal ultrasonography for assessing morbidity from schistosomiasis. 2. Hospital studies.

M F Abdel-Wahab1, G T Strickland.   

Abstract

Abdominal ultrasound, which uses a pulse echo device to record reflected waves of a sound beam in 2 dimensions, has revolutionized the evaluation of schistosomal morbidity. It is relatively inexpensive, rapid, simple to perform and portable, causes no biological hazards to the subject and, because of its speed, is ideal for diagnosis and directing interventions, e.g., biopsies. Ultrasound complements or replaces intravenous pyelography, cystoscopy, endoscopy, liver biopsy, angiography and other invasive techniques for studying morbidity due to schistosomiasis. The sensitivity and specificity of ultrasound, in comparison to these other procedures, for detecting schistosomal lesions has been between 80% and 100%, with the exception of detection of hydroureter, ureteral calculi and calcified bladder. Ultrasound is the best method for measuring liver and spleen size and configuration; detecting and grading periportal fibrosis, portal hypertension, hydronephrosis and urinary bladder wall lesions; and for demonstrating renal and bladder stones.

Entities:  

Mesh:

Year:  1993        PMID: 8337709     DOI: 10.1016/0035-9203(93)90459-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

Review 1.  Gastrointestinal manifestations of schistosomiasis.

Authors:  G T Strickland
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

2.  Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.

Authors:  Chikwendu J Ede; Dimitrinka Nikolova; Martin Brand
Journal:  Cochrane Database Syst Rev       Date:  2018-08-03

3.  Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis.

Authors:  Alexandre S Pyrrho; Henrique Leonel Lenzi; Juliene Antonio Ramos; Roberto Moura-Neto; Fabio Christiane O F Cachem; Célia Santos da Silva; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  Parasitol Res       Date:  2004-03-04       Impact factor: 2.289

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.